A Comparison of High and Usual Protein Dosing in Critically Ill Patients With Obesity: A Post Hoc Analysis of an International, Pragmatic, Single-Blinded, Randomized, Clinical Trial

医学 加药 析因分析 体质指数 随机化 随机对照试验 人口 危险系数 肥胖 子群分析 内科学 病危 临床试验 荟萃分析 置信区间 环境卫生
作者
Lauren Tweel,Charlene Compher,Danielle E. Bear,Pedro Gutiérrez‐Castrellón,Susannah Leaver,Kristen MacEachern,Luis Ortiz‐Reyes,Lakhani Pooja,Alba León,Courtney Wedemire,Zheng‐Yii Lee,Andrew G. Day,Daren K. Heyland
出处
期刊:Critical Care Medicine [Ovid Technologies (Wolters Kluwer)]
卷期号:52 (4): 586-595 被引量:1
标识
DOI:10.1097/ccm.0000000000006117
摘要

Across guidelines, protein dosing for critically ill patients with obesity varies considerably. The objective of this analysis was to evaluate whether this population would benefit from higher doses of protein.A post hoc subgroup analysis of the effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicenter, pragmatic, registry-based randomized trial.Eighty-five adult ICUs across 16 countries.Patients with obesity defined as a body mass index (BMI) greater than or equal to 30 kg/m 2 ( n = 425).In the primary study, patients were randomized into a high-dose (≥ 2.2 g/kg/d) or usual-dose protein group (≤ 1.2 g/kg/d).Protein intake was monitored for up to 28 days, and outcomes (time to discharge alive [TTDA], 60-d mortality, days of mechanical ventilation [MV], hospital, and ICU length of stay [LOS]) were recorded until 60 days post-randomization. Of the 1301 patients in the primary study, 425 had a BMI greater than or equal to 30 kg/m 2 . After adjusting for sites and covariates, we observed a nonsignificant slower rate of TTDA with higher protein that ruled out a clinically important benefit (hazard ratio, 0.78; 95% CI, 0.58-1.05; p = 0.10). We found no evidence of difference in TTDA between protein groups when subgroups with different classes of obesity or patients with and without various nutritional and frailty risk variables were examined, even after the removal of patients with baseline acute kidney injury. Overall, 60-day mortality rates were 31.5% and 28.2% in the high protein and usual protein groups, respectively (risk difference, 3.3%; 95% CI, -5.4 to 12.1; p = 0.46). Duration of MV and LOS in hospital and ICU were not significantly different between groups.In critically ill patients with obesity, higher protein doses did not improve clinical outcomes, including those with higher nutritional and frailty risk.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
5秒前
Hello应助想人陪的新瑶采纳,获得10
9秒前
Mister_CHEN完成签到,获得积分10
12秒前
nalan发布了新的文献求助10
13秒前
13秒前
彭宝淦完成签到,获得积分10
14秒前
15秒前
20秒前
SciGPT应助和谐的乌冬面采纳,获得20
22秒前
充电宝应助lihaifeng采纳,获得10
24秒前
25秒前
呆鸥完成签到,获得积分10
27秒前
27秒前
太吾墨完成签到,获得积分10
30秒前
阿斯顿发布了新的文献求助10
30秒前
CC0113发布了新的文献求助10
33秒前
SOLOMON应助杨羕采纳,获得10
35秒前
37秒前
37秒前
zeroayanami0完成签到,获得积分10
40秒前
jler完成签到 ,获得积分10
43秒前
43秒前
瀚森完成签到 ,获得积分10
45秒前
干净的人达完成签到 ,获得积分10
48秒前
Simpson完成签到 ,获得积分10
48秒前
51秒前
boom完成签到 ,获得积分10
52秒前
52秒前
YIBO发布了新的文献求助10
55秒前
健康的电灯胆完成签到,获得积分10
57秒前
sp发布了新的文献求助10
57秒前
Away完成签到 ,获得积分10
1分钟前
shinysparrow应助纪外绣采纳,获得200
1分钟前
wenxiansci完成签到,获得积分0
1分钟前
Ava应助ww立采纳,获得10
1分钟前
丘比特应助科研通管家采纳,获得10
1分钟前
秋雪瑶应助科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
Sphäroguß als Werkstoff für Behälter zur Beförderung, Zwischen- und Endlagerung radioaktiver Stoffe - Untersuchung zu alternativen Eignungsnachweisen: Zusammenfassender Abschlußbericht 1500
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
[Lambert-Eaton syndrome without calcium channel autoantibodies] 520
The Three Stars Each: The Astrolabes and Related Texts 500
india-NATO Dialogue: Addressing International Security and Regional Challenges 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2469799
求助须知:如何正确求助?哪些是违规求助? 2136971
关于积分的说明 5444880
捐赠科研通 1861323
什么是DOI,文献DOI怎么找? 925714
版权声明 562721
科研通“疑难数据库(出版商)”最低求助积分说明 495151